Geron
Presence
Geron is one of the...
Geron is a company listed under the stock ticker GERN (US).
Acquisition, funding and merger involving Geron.
- Geron has just announced a $198 Million fundraising (posted on January 11 2023).
Executives
View the org chart displaying its 22 main executives
Most searched biographies at Geron
- John Scarlett, Chief Executive Officer and Chairman of the Board
- Robert Spiegel, Director
- Gaurav Aggarwal, Director
Popular executive movements at Geron
- Gaurav Aggarwal has joined the company as Director (posted on November 29 2023).
- Michelle Robertson has joined the company as Executive Vice President, Chief Financial Officer and Treasurer (posted on September 12 2023).
- Olivia Bloom, Executive Vice President, Finance, Chief Financial Officer and Treasurer, is retiring (posted on September 12 2023).
Create your alert
to follow the executive moves at Geron.
Biotechnology
Geron has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Geron
- Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
- Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS
- Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
- Geron Announces PDUFA Date for Imetelstat NDA in Lower Risk MDS
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Geron Announces FDA Acceptance of New Drug Application for Imetelstat for the Treatment of Lower Risk MDS
- Geron Corporation Reports Business Highlights and Second Quarter 2023 Financial Results
- Geron to Announce Second Quarter 2023 Financial Results on August 3, 2023
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Geron Announces U.S. Expanded Access Protocol for Imetelstat in Lower Risk MDS
- View more press releases Close
Social media about Geron
- Geron on Wikipedia, Google News & Yahoo Finance
- Geron on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Gaurav Aggarwal 
